Zobrazeno 1 - 10
of 1 399
pro vyhledávání: '"Damm, O"'
Publikováno v:
In CIRP Journal of Manufacturing Science and Technology August 2021 34:47-60
Autor:
Byrne, G., Damm, O., Monostori, L., Teti, R., van Houten, F., Wegener, K., Wertheim, R., Sammler, F.
Publikováno v:
In CIRP Journal of Manufacturing Science and Technology August 2021 34:6-21
Autor:
Wick M; Evidence-based Medicine / Health Economics & Outcomes Research, Sanofi-Aventis Deutschland GmbH, Berlin, Germany., Kliemt R; Health Services Research and Health Economics, WIG2 GmbH, Leipzig, Germany., Poshtiban A; Evidence-based Medicine / Health Economics & Outcomes Research, Sanofi-Aventis Deutschland GmbH, Berlin, Germany., Kossack N; Health Services Research and Health Economics, WIG2 GmbH, Leipzig, Germany., Diller GP; Adult Congenital and Valvular Heart Disease Center, Department of Cardiology and Angiology, University Hospital Muenster, Muenster, Germany.; Competence Network for Congenital Heart Defects, Deutsches Herzzentrum Berlin, Berlin, Germany., Soudani S; Health Economics & Value Assessment Vaccines, Sanofi Vaccines, Lyon, France., Bangert M; Health Economics & Value Assessment Vaccines, Sanofi Vaccines, Lyon, France., Kramer R; Health Economics & Value Assessment Vaccines, Sanofi Vaccines, Lyon, France., Damm O; Evidence-based Medicine / Health Economics & Outcomes Research, Sanofi-Aventis Deutschland GmbH, Berlin, Germany.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2380110. Date of Electronic Publication: 2024 Aug 08.
Autor:
Schindler CJA; WIG2 GmbH, Markt 8, 04109, Leipzig, Germany., Wittenberg I; Institute of Medical Epidemiology, Biometry and Informatics, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 8, 06108, Halle (Saale), Germany., Damm O; Sanofi-Aventis Deutschland GmbH, Lützowstr. 107, 10785, Berlin, Germany., Kramer R; Sanofi-Aventis Deutschland GmbH, Lützowstr. 107, 10785, Berlin, Germany., Mikolajczyk R; Institute of Medical Epidemiology, Biometry and Informatics, Medical Faculty, Martin Luther University Halle-Wittenberg, Magdeburger Str. 8, 06108, Halle (Saale), Germany., Schönfelder T; WIG2 GmbH, Markt 8, 04109, Leipzig, Germany. tonio.schoenfelder@wig2.de.; Chair Health Sciences/Public Health, Faculty of Medicine, Technische Universität Dresden, Fetscherstr. 74, 01307, Dresden, Germany. tonio.schoenfelder@wig2.de.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2024 Nov; Vol. 13 (11), pp. 2333-2350. Date of Electronic Publication: 2024 Sep 19.
Publikováno v:
In Annals of Oncology July 2019 30(7):1061-1070
Autor:
Poshtiban A; Sanofi-Aventis Deutschland GmbH, Lützowstr. 107, 10785, Berlin, Germany. anahita.poshtiban@sanofi.com., Wick M; Sanofi-Aventis Deutschland GmbH, Lützowstr. 107, 10785, Berlin, Germany., Bangert M; Sanofi Vaccines, Lyon, France., Damm O; Sanofi-Aventis Deutschland GmbH, Lützowstr. 107, 10785, Berlin, Germany.
Publikováno v:
BMC infectious diseases [BMC Infect Dis] 2024 Aug 20; Vol. 24 (1), pp. 844. Date of Electronic Publication: 2024 Aug 20.
Modelling the Public Health Impact of MenACWY and MenC Adolescent Vaccination Strategies in Germany.
Autor:
Gruhn S; Department for Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitätsstraße 25, 33615, Bielefeld, Germany. s.gruhn@uni-bielefeld.de., Batram M; Vandage GmbH, Detmolder Straße 30, 33604, Bielefeld, Germany., Wick M; Sanofi-Aventis Deutschland GmbH, Lützowstraße 107, 10785, Berlin, Germany., Langevin E; Sanofi Vaccines, 14 Espace Henry Vallee, 69007, Lyon, France., Scholz S; Martin-Luther-University Halle-Wittenberg, Magdeburgerstr. 20, 06112, Halle (Saale)., Germany., Greiner W; Department for Health Economics and Health Care Management, School of Public Health, Bielefeld University, Universitätsstraße 25, 33615, Bielefeld, Germany., Damm O; Sanofi-Aventis Deutschland GmbH, Lützowstraße 107, 10785, Berlin, Germany.
Publikováno v:
Infectious diseases and therapy [Infect Dis Ther] 2024 Apr; Vol. 13 (4), pp. 907-920. Date of Electronic Publication: 2024 Apr 04.
Publikováno v:
South African Journal of Industrial Engineering. Dec2021, Vol. 32 Issue 4, p13-27. 15p.
Autor:
Wick M; Sanofi-Aventis Deutschland GmbH Berlin Germany., Poshtiban A; Sanofi-Aventis Deutschland GmbH Berlin Germany., Kramer R; Sanofi-Aventis Deutschland GmbH Berlin Germany., Bangert M; Sanofi-Aventis Deutschland GmbH Berlin Germany., Lange M; Department of Pediatric Pneumology and Allergology Universitätsklinik für Kinder- und Jugendmedizin Oldenburg Oldenburg Germany., Wetzke M; Department of Pediatric Pneumology, Allergology and Neonatology Hannover Medical School Hannover Germany.; Biomedical Research in End-Stage and Obstructive Lung Disease Hannover (BREATH) Hannover Germany., Damm O; Sanofi-Aventis Deutschland GmbH Berlin Germany.
Publikováno v:
Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2023 Nov; Vol. 17 (11), pp. e13211.
Autor:
Horn, J., Damm, O., Kretzschmar, M.E.E., Deleré, Y., Wichmann, O., Kaufmann, A.M., Garbe, E., Krämer, A., Greiner, W., Mikolajczyk, R.T.
Publikováno v:
In Vaccine 1 May 2013 31(19):2372-2380